New RSL Therapy Offers Respite to Medication-Refractory Patients

The therapy was found to provide a “substantial reduction” in symptoms for adult patients with RLS refractory to medications.

Related Keywords

Massachusetts ,United States ,Cross Sylvia ,John Winkelman ,Shri Raghunathan ,Disorders Clinical Research Program At Massachusetts ,Noctrix Health ,Noctrix Health Inc ,Drug Administration ,Breakthrough Device Designation ,Clinical Sleep ,Sleep Disorders Clinical Research Program ,Massachusetts General Hospital ,